Introduction
Gliomas are primary brain tumors arising from the supporting cells of the brain or spinal cord. Accounting for .30% of all primary brain and central nervous system (CNS) malignant tumors, gliomas are the most common tumors of the CNS. They involve almost 80% of primary malignant type of brain tumors and are responsible for a higher rate of mortality than other forms. 1 Overall incidence rate for primary malignant brain and CNS tumors is estimated to be 7.27/100,000 per year for all age groups.
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lu et al grow invasively and cause discernible neurologic symptoms within months with an extremely poor prognosis. Even treated with aggressive open surgery combined with adjuvant chemo/ radiotherapy, the median survival time is still ,15 months, [5] [6] [7] [8] and current treatment paradigms appear to have reached their maximum benefit. Therefore, for decades, considerable efforts have been devoted to developing more effective antitumor agents and better strategies for targeting human glioma. 9, 10 Recently, nanostructures with combined diagnostic and therapeutic functions represent a potential application for tumor therapy. [11] [12] [13] [14] Many inorganic nanoparticles with various compositions, physical features, and functionalities have been widely synthesized and used as drug vehicles, for instance, polymer Prussian blue, zeolitic imidazolate framework, alginate, and calcium phosphate. [15] [16] [17] [18] Likewise, metal nanoparticles and their oxides with special shapes (sphere, tadpole, and pearl chain) have been successfully generated. Magnetic nanoparticles (MNPs), such as iron oxide, have been widely studied because of their combination of properties such as superparamagnetism, biocompatibility, and ease of synthesis. The most common form of iron oxide used is magnetite (Fe 3 O 4 ) with a tendency to oxidize, which alters its magnetic properties. 19 That is why iron oxide nanoparticles are generally coated with a biocompatible layer such as polymers, silica, or gold (Au). [20] [21] [22] [23] [24] [25] [26] [27] In particular, core-shell-structured Fe 3 O 4 @Au composite MNPs have been the focus of study owing to their intriguing bifunctional properties. 28, 29 As a form of multifunctional magnetoplasmonic nanomaterials, the nanoparticles combining Au and magnetic materials inherit from the two components excellent surface chemistry, special optical properties, and superparamagnetic properties, all of which would greatly enhance the potential and broaden the practical applications of such nanomaterials. 30 Advances in the area of nanotechnology have contributed to the development of magnetic fluid hyperthermia (MFH). In vivo MFH is expected to be one of the best solutions for destroying tumor cells that are deeply seated and localized inside the human body for unlimited tissue penetration and the possibility of multiple hyperthermia cycles. Additionally, high selectivity and heating homogeneity can be expected in the use of MFH. Nevertheless, the practical limitation with MFH is that heating efficiency declines markedly when nanoparticles are taken up by cancer cells, because their endocytosis and aggregation inhibit their Brownian motion. Similarly, the diffusion (thereby local dilution) or enhanced distribution of nanoparticles also decreases nanoparticle heating. 31 The drawbacks of MFH could be overcome by combination with near-infrared (NIR) hyperthermia. With local plasmonic heating caused by NIR laser excitation, its efficiency is not impacted by intracellular confinement. 31 As a form of multifunctional magnetoplasmonic nanomaterials, Fe 3 O 4 @Au composite MNPs are the designs of choice to implement a magneto-photothermal strategy to optimize nanoparticles' heating efficiency.
We previously reported self-prepared Fe 3 O 4 @Au composite MNPs, which are intrinsically magnetic, and exhibit high biocompatibility and safety according to the evaluation of toxicity in vivo and in vitro. 32 Moreover, these MNPs have a potential to be used as safe optical and thermal agents, allowing the combination of cancer detection and cancerspecific hyperthermic treatment. 32 The present study is aimed at the functionalization of Fe 3 @Au MNPs (0.5 mg Fe/mL, 2.5 mL) whose value of pH was adjusted to 9.0 by HCl (0.1 mol/L), and the mixture was placed in a temperature-controlled shaker at 200 rpm for 2 h at a given temperature of 37°C, followed by BSA (1%, 100 μL) added for reaction for 30 min. At the end of the adsorption, the supernatant and Fe 3 O 4 @Au-C225 MNPs were separated by means of a permanent magnet, and the obtained precipitate was dissolved in BSA (1%, 1 mL) and stored at 4°C for further use.
Characterization of Fe 3 O 4 @Au-C225 MNPs
The morphology of Fe 3 O 4 @Au-C225 MNPs was characterized using transmission electron microscopy (TEM; JEM-1011; JEOL, Tokyo, Japan) and scanning electron microscopy (SEM; JSM-6360LV; JEOL, Tokyo, Japan). The mean particle size and zeta potential were measured using Malvern Instruments (Malvern, UK). The optical properties and magnetic property were measured using 752 Prismatic UV−vis spectroscopy (Shanghai Precision Scientific Instrument Co., China) and vibrating sample magnetometer (PPMS-9; Quantum Design, USA). 
Determination
Adsorption efficiency measurements
To determine the antibody absorption efficiency, the FITCconjugated AffiniPure Goat Anti-Human IgG was added to 2 μL of Fe 3 O 4 @Au-C225 MNPs with 1% BSA and allowed to react for 1 h at 37°C in the dark. After separated by means of a permanent magnet, the precipitate was washed three times with PBS, redispersed in 20 μL of PBS, and observed under a confocal laser scanning microscope (Leica TCS SP8 STED 3×). Fe 3 O 4 @Au-C225 MNPs that were not incubated with FITC-conjugated AffiniPure Goat Anti-Human IgG were used as control. The image data were processed with ImageJ software 1.8.
The effective Fc binding of C225 toward the surface of the Fe 3 O 4 @Au MNPs was also investigated by enzyme-linked immunosorbent assay according to the literature procedure. 34 Goat Anti-Human IgG (Fc)-horseradish peroxidase (HRP) was, respectively, added into an aqueous solution of Fe 3 O 4 @ Au-C225 MNPs (100 μL) at dilutions of 1:500, 1:1,000, 1:2,000, 1:4,000, 1:8,000, and 1:16,000, and incubated for 1 h at 37°C. After separated by means of a permanent magnet (60 min, 4°C), supernatant (100 μL) was then collected, and ortho-phenylenediamine substrate solution was added at room temperature protected from light. After 10 min, the reaction was stopped by adding H 2 SO 4 (2 mol/L, 50 μL). Part of the dye solution was transferred and the OD was measured at 492 nm with a plate reader. Served as control, treatment of Fe 3 O 4 @Au-BSA and C225 mixture followed the same procedure described above.
Heating test of the Fe 3 O 4 @Au-C225 MNPs
The Fe 3 O 4 @Au-C225 MNPs' magnetothermal and photothermal effects were tested in aqueous suspensions as a function of [Fe] concentrations, ranging from 0.25 to 1.25 mg Fe/mL. The [Fe] concentrations of the samples dispersed in deionized water were analyzed using Leeman Prodigy inductively coupled plasma-optical emission spectroscopy (USA). Three heating protocols were selected: 1) alternating magnetic field (AMF) alone, at an output frequency of 230 kHz and an output current of 30 A; 2) NIR laser alone at 635 nm laser with 0.3 W/cm²; and 3) combined hyperthermia (simultaneous application of both AMF and NIR). Four plates were exposed to nonhyperthermia or AMF alone or NIR alone or AMF+NIR, respectively. Nonhyperthermia plate was exposed to no heat treatment. AMF plate was placed into AMF (f=230 kHz, I=30 A) for 30 min. NIR plate was treated with NIR laser (λ=635 nm, 0.3 W/cm 2 ) for 30 min. AMF+NIR plate was possessed with simultaneous application of both AMF and NIR. After incubation for an additional 24 h, the cell viability was measured by a standard MTT method and the cell absorbance was measured at an OD of 492 nm. The cell relative growth rate (RGR) was calculated as (OD of experimental group/OD of blank control group)×100%. Quantitative real-time polymerase chain reaction (qRT-PCR) U251 cells were divided and treated according to the protocol described in the study using flow cytometer assay. After treatment, total RNA was extracted from groups of cells using RNAiso Reagent from Takara and dissolved in DEPC-treated water. Reverse transcription was performed with a 20 μL total volume comprising 2 μL of extracted RNA, 1 μL of Takara Oligo dT l8 , 2 μL of Takara dNTP (10 mM), 0.5 μL of Takara RNasin, 1 μL of Takara AMV, 4 μL of 5× AMV Buffer, and 9.5 μL of DEPC-treated water. The qRT-PCR was performed in a 25 μL total volume comprising 2 μL of 10× PCR buffer, 2 μL of Takara dNTP (2.5 mM), 1 μL of 5′ primer (20 pmol/μL), 1 μL of 3′ primer (20 pmol/μL), 0.5 μL of Takara TaqE (5 U/μL), 2.5 μL of MgCl 2 (25 mM), 11 μL of DEPC-treated water, and 5 μL of cDNA on the PTC-100 (MJ Research, Inc., Watertown, MA, USA). The sequences of the specific primers used in the research were as follows: caspase-3 -forward: 5′-AAACAGTATGCCGACAAG-3′ and reverse: 5′-GAGGGAAATACAGTACCAAA-3′; caspase-8 -forward: 5′-AAAGGGAACTTCAGACACC-3′ and reverse: 5′-CAGCAGGCTCTTGTTGAT-3′; caspase-9 -forward: 5′-CGAACTAACAGGCAAGCA-3′ and reverse: 5′-TTCACCTCCACCATGAAAT-3′; β-actin -forward: 5′-CGTCTGGACCTGGCTGGCCGGGACC-3′ and reverse: 5′-CATGAAGCATTTGCGGTGGACGATG-3′. The melting curve and threshold cycle data for each PCR product were determined and analyzed.
MTT assay of antiproliferative effect
Flow cytometry evaluation of cell apoptosis
Western blotting U251 cells were divided and treated according to the protocol described in the study using flow cytometry assay. Cells under different treatments were lysed, and the protein concentrations were assessed using Bradford assay. Proteins were separated using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred from gel to polyvinylidene difluoride 
Tumor growth evaluation
The mice were killed on day 42 after the initial treatment. The quality and volume of stripped tumors were measured. Tumors and major organs (heart, liver, spleen, kidneys, lungs, and tumor) were surgically removed at the end of the treatment after killing. The tissues were fixed in 4% formaldehyde and embedded in paraffin, sectioned into thick slices, and stained with hematoxylin/eosin. Ultrastructural characteristics of the tumor were observed by TEM.
Statistical analysis
All statistical analyses were performed using SPSS version 19.0 software (SPSS Inc., Chicago, IL, USA). Results were expressed as mean ± SD. Statistically significant differences were assessed via analysis of variance. Statistical significance was set at P,0.05. 
Results
Preparation and characterization of Fe 3 O 4 @Au-C225 MNPs
Heat generation by Fe 3 O 4 @Au-C225 MNPs in suspension
The iron concentrations of the Fe 3 O 4 @Au-C225 MNPs were ranging from 0.25 to 1.25 mg Fe/mL. When varying concentrations of Fe 3 O 4 @Au-C225 MNPs were exposed to AMF, the temperature rose rapidly within the first 30 min, then rose gently, and stabilized at a certain level after 50 min ( Figure 5A ). When exposed to NIR, the temperature rose rapidly within the first 15 min and stabilized at a certain level after 30 min ( Figure 5B ). When exposed to AMF+NIR, the temperature rose rapidly within the first 15 min and stabilized at a certain level after 20 min ( Figure 5C ). In three heating protocols, the rise in temperature increased with the iron concentration. Among all of the tested concentrations, 0.5 mg Fe/mL was the optimum. This hyperthermic behavior contributes to the killing of tumor cells while not harming normal tissues. In addition, Fe 3 O 4 @Au-C225 MNPs with the concentration of 0.5 mg Fe/mL exhibited a sufficient heating capacity (specific absorption rate [SAR]=84.56, intrinsic loss power [ILP]=0.018) to achieve satisfactory temperatures, which were selected in the following experiments. Temporal Figure 5D .
Tumor cell proliferation and cellular apoptosis study in vitro Figure 6B and C), indicating the highest antiproliferative activity against U251 cells in this study.
For further investigation of the antiproliferative effect, the cell cycle progression was measured using flow cytometry. Results showed that S arrest was prominent in U251 cells exposed to Fe 3 O 4 @Au-C225 MNPs with or without hyperthermia (Figure 7) . We also observed an increase in the Figure 8A-D) . In addition, a marked upregulation of caspase-3, caspase-8, and caspase-9 expression, particularly caspase-3 and caspase-9, was evaluated using the cells treated with 
Discussion
The combination of chemotherapy and thermotherapy has been the focus of cancer therapy in recent years. However, one of the challenges encountered was to achieve the optimal effects of the combination therapy. Thus, a robust therapeutic platform is urgently needed to achieve the most effective synergic effect for tumor therapy.
The importance of EGFR in the malignant progression of glioblastoma and the effect of EGFR on patient survival has been extensively documented. Overexpressed EGFR is present in up to 40% of primary glioblastoma and the common overexpression makes EGFR a theoretically attractive target, and consequently, EGFR inhibitors have been among the most studied in clinical trials. [35] [36] [37] [38] C225, an IgG1 human-murine chimeric of McAb M225 from murine, has been approved for use in patients with head and neck cancer, which is the only EGFR inhibitor that has conferred a survival advantage when combined with platinum-based combination chemotherapy. 39 In this study, we decorated Fe 3 O 4 @Au composite MNPs with C225 via physical adsorption in order to maintain the biologic activities of C225. The green fluorescence observed by confocal laser scanning microscope ( Figure 3A and B) Figure 2C ), suggesting the excellent adsorption of C225. In addition, zeta potential and particle size are two important factors. The size of the nanoparticle may have an effect on uptake efficiency. The Fe 3 O 4 @Au-C225 MNPs that we synthesized revealed a diameter of 46 nm with a zeta potential of 11.1±1.8 mV. It is known that a nanoparticle with a positive charge has more efficient cellular internalization than a nanoparticle with a neutral or negative charge. 40, 41 Cell surface usually has a negative charge; therefore, In our cell studies, MTT assay showed that the combined hyperthermia (MFH+NIR) mediated by Fe 3 O 4 @Au-C225 MNPs significantly decreased the U251 cell viability compared to sole hyperthermia (MFH or NIR), suggesting the optimizing heating efficiency. In addition, the highly antiproliferative effect of combined hyperthermia (MFH+NIR) mediated by Fe 3 O 4 @Au-C225 MNPs against U251 cells was also observed compared to that mediated by Fe 3 O 4 @Au MNPs groups, confirming the significant role of C225 in the targeting to U251 cells with overexpressed EGFR. For further investigation of the antiglioma effect, the cell cycle progression was measured using flow cytometry, and then qRT-PCR and Western blot analyses were performed to evaluate the molecular mechanisms of induced apoptosis. The combined hyperthermia (MFH+NIR) mediated by Fe 3 O 4 @Au-C225 MNPs exhibited excellent therapeutic efficacy for U251 cells by induction of apoptosis ( Figure 7 ). Furthermore, a marked upregulation of caspase-3, caspase-8, and caspase-9 expression, particularly caspase-3 and caspase-9, was evaluated using the cells treated with Fe 3 O 4 @Au-C225 MNPsmediated combined hyperthermia (MFH+NIR), indicating its excellent antitumor effect by inducing intrinsic apoptosis (Figure 8) .
Evaluation of animal models displayed that therapeutic efficacy of Fe 3 O 4 @Au-C225 MNPs-mediated combined hyperthermia (MFH+NIR) was superior compared to sole hyperthermia (MFH or NIR) and Figure 9E ).
Structural modification of nanoparticles with targeting ligands like aptamers, short peptides, and other small molecules has been found to increase the accumulation of nanoparticles at the tumor site just because the ligands can recognize special and unique biophysical markers on the surface of tumor cells. [42] [43] [44] Therefore, in our study, designed Fe 3 O 4 @Au-C225 composite-targeted MNPs with C225, with high affinity for EGFR, caused to enhanced efficacy of cellular MNPs uptake through receptor-dependent C225-mediated endocytosis and antiglioma effect of C225 itself. Subsequently, the simultaneous application of both MFH and NIR hyperthermia contributes to intrinsic apoptosis of U251 glioma cells and enhanced efficacy in tumor size reduction. We developed a robust therapeutic platform for glioma therapy based on Fe 3 O 4 @Au-C225 composite-targeted MNPs. On the basis of the experimental results of this study, MFH combined with NIR hyperthermia mediated by Fe 3 O 4 @ Au-C225 composite-targeted MNPs will show promise in future human clinical trial for patients with glioma. 
